INVESTOR PRESENTATION - GENETIC SIGNATURES LIMITED
GENETIC SIGNATURES LIMITED
Health Care
Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.
Market Cap
323.73m
Price at Close
$2.27
4w avg. Volume
233.73k
4w avg. Turnover
$591.10k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| 0.00% | 07 Aug 2020 |
| -6.74% | 27 Jul 2020 |
| -6.74% | 27 Jul 2020 |
| -6.10% | 24 Jun 2020 |
| -3.33% | 17 Jun 2020 |
| -7.51% | 11 Jun 2020 |
| +2.50% | 28 May 2020 |
| -2.55% | 12 May 2020 |
| -3.65% | 10 May 2020 |
| +3.16% | 29 Apr 2020 |
Market Data
Current Price
$2.27
52WK HIGH
$2.94
52WK LOW
$0.9
1YR RETURN
+116.19%
1YR RETURN VS. SECTOR
-45.84%
90 DAY RETURN
+21.39%
ASX RANK
431
/2,032
SECTOR RANK
1
/9
SHARES OUTSTANDING
142.61m
GENETIC SIGNATURES LIMITED
Health Care
Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.
Market Cap
323.73m
Price at Close
$2.27
4w avg. Volume
233.73k
4w avg. Turnover
$591.10k
ASX:GSS is not raising right now
Want to invest?
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Contact Us
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia
(03) 9028 2888
deals@freshequities.com
Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.